Published in Cancer Weekly, November 11th, 2003
This randomized prospective phase III study of palliative external beam radiotherapy was conducted for patients with breast or prostate cancer and painful bone metastases. More than 160 hospitals and universities in the United States and Canada participated in the study.
Eligible patients, 897 of the 949 enrolled, had moderate to severe pain, radiographic evidence of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.